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Summary: Distribution-free statistical procedures should be applied to the establishment of assigned values and
uncertainty intervals in a control serum. The two problems, how to find an appropriate statistical evaluation proce-
dure and how to find an optimized experimental design, are simultaneously dealt with here: Three distribution-free
procedures are presented, each based on elimination of extreme values, and 60 designs are considered differing with
respect to the number of reference laboratories, of independent series, and of single or double determinations. Using
the data of the study described in part 1 of this series (Passing, H. et al. (1981) this j. 19,1137-1144) we simulated
these designs and the pertaining assigned values and uncertainty intervals given by each evaluation procedure.
From this study one evaluation procedure is shown to be superior to others. This optimized procedure has the follow-
ing characteristics: Extreme values are eliminated so that the width of the uncertainty interval is as small as possible.
The median of the remaining values is the assigned value. Moreover, 6 reference laboratories are shown to be appro-
priate.
Vergleich von drei verteilungsfreien Verfahren fur die Ermittlung von Sollwerten in Kontrollseren.
Ermittlung von Sollwerten in Kontrollseren, Hl.
Zusammenfassung: Für die Ermittlung von Sollwerten und Sollbereichen eines Kontrollserums sollten verteilungs-
freie statistische Verfahren angewandt werden. Die beiden Probleme, wie man ein geeignetes statistisches Auswer-
tungsverfahren und wie man einen optimierten Meßplan findet, werden hier simultan behandelt: Drei verteilungs-
freie Verfahren werden dargestellt, von denen jedes auf der Elimination extremer Werte beruht, und 60 Meßpläne
werden berücksichtigt, die sich in der Anzahl der Referenzlaboratorien, der unabhängigen Serien und in Einzel-
öder Doppelbestimmungen unterscheiden. Indem wir die Daten der in Teil l dieser Reihe (Passing, H. et al. (1981)
this j. 19,1137—1144) beschriebenen Studie benutzten, simulierten wir diese Meßpläne und die von jedem Ver-
fahren gegebenen zugehörigen Sollwerte und Sollbereiche.
Aus dieser Studie wird abgeleitet, daß ein Auswertungsverfahren anderen überlegen ist. Dieses optimierte Verfahren
ist folgendermaßen charakterisiert: Extremwerte werden so eliminiert, daß der Sollbereich möglichst geringe Breite
hat. Der Mediän der verbleibenden Werte ist der Sollwert. Außerdem wird gezeigt, daß 6 Referenzlaboratorien ange-
messen sind.
Introduction thus resulting in misleading or seriously wrong assigned
. , values and uncertainty intervals. Therefore it has been
In part 2 of this series (3) we discussed four statistical concluded that a distrjbution-free procedure should be
models which are partly applied to the establishment of ..ed jn or(Jer have an evaluation ugotithm which
assigned values of a control serum and their uncertainty b universaj,y appropriate to ali constituents in all con-
intervals. They are based on assumptions concerning ^ sm Th-s conse ence is also given jn ,. C- (4)-
normal distribution and equality of precision of analyti-
cal values each in a characteristic manner. It has been Furthermore, it has been discussed (3) that models based
shown that such assumptions will in general be erroneous on differences in accuracy between the reference labora-
tories are necessarily inappropriate if they do not con-
*) A preliminary report is given in I.e. (1). tain any variation of accuracy between customers. All
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such models based on an analysis of variance fail: They
give a prediction interval for one analytical value of the
customer assumed to be centered at the general mean
of the reference laboratories, whereas the width of the
interval does not cover any differences of accuracy. In
fact, a theoretical model has not been developed up to
now which, covers differences of accuracy both between
reference laboratories (being estimable) and between
customers (being a priori unknown).
Consequently it seems reasonable to pool all the analyti-
cal values of the reference laboratories. In this paper we
present three such procedures.
However, the choice of a statistical procedure may
depend on the underlying experimental design i.e. the
number of reference laboratories to be incorporated
with the number of independent series and the number
of determinations per series. Experimental designs
proposed (4, 5) or mentioned (6) vary from 3 up to 10
laboratories and with respect to the number and the
arrangement of values within laboratories. Conversely,
an optimized design generally depends on the statistical
procedure which is to be applied to evaluation. There-
fore, it is necessary to elaborate an optimized design
and an appropriate evaluation procedure simultaneously.
In this paper we show one evaluation procedure to be
superior, and we determine the appropriate number of
reference laboratories. The other details of an optimized
design will be derived (7) by using the methods devel-
oped here. These two papers form a unit.
Materials and Methods
We used the experimental data of the study described in I.e. (2).
The analyses were performed by laboratories of members of the
Verband der Diagnostica- und Diagnosticager te-Hersteller
(VDGH, Association of Diagnostics and Diagnostics Instrumen-
tation Manufacturers). The study covered the constituents
creatinine, glucose, urea, alanine and aspartate aminotransferase2),
creatine kinase2), and 7-glutamyltransf erase2). For each con-
stituent we had 9 to 11 laboratories (see tab. 1) each having per-
formed double determinations in approximately 18 independent
series of the unknown sample, of the known control, and of a
blind control. But we processed only those data which had met
the respective validity criterion as given in I.e. (3). In doing so
at least 15 series were found valid in each laboratory and each
constituent. Therefore we confined ourselves to the first 15
valid series of each laboratory and constituent; data from
further series were neglected (if any).
We considered the following statistical procedures for the
evaluation of an arbitrary design consisting of I laboratories
each with J independent series and K determinations per
series, respectively. At first, these data are pooled and sorted
2) Enzymes: Glutamate-pyruvate-transaminase = alanine amino-
transferase = L-alanine: 2-oxoglutarate aminotransferase
EC 2.6.1.2;glutamate-oxalacetate-transaminase = aspartate
aminotransf erase = L-aspartate: 2-oxoglutarate aminotrans-
ferase EC 2.6.1.1; 7-glutamyltransf erase = (5-glutamyl)-
peptide: aminoacid 5-glutamyltransferase EC 2.3.2.2;
creatine kinase = ATP: creatine N-phosphotransferase
EC 2.7.3.2.
resulting in n values xi < X2 < ... < xn with n = I · J · K.
As the uncertainty intervals are to contain at least 95% of the
analytical results, up to 5 % have to be eliminated. From n we
derive m = 5 n/100, which is rounded off. Then:
Procedure 1
m of the n values are eliminated so that the range of the remain-
ing values is as short as possible. The extreme values of the
remaining ones are the uncertainty limits. The arithmetic mean
of these limits is the assigned value.
Procedure 2
m of the n values are eliminated so that the range of the remain-
ing values is as short as possible. The extreme values of the
remaining ones are the uncertainty limits (identical to pro-
cedure 1). The median of the remaining values is the assigned
value.
Procedure 3
From m we derive m* = m/2 which is rounded off. The m*
smallest values Xj ... xm* and m* greatest values Xfi-m* + 1
... xn are eliminated. The extremes of the femaining ones
i.e. xm* + é and xn_m* are the uncertainty limits. The median
of the remaining values is the assigned value.
Especially, for ç < 20 no value is eliminated, and for 20 < ç < 40
exactly one value is eliminated in the procedures 1 and 2, but
none in procedure 3.
Furthermore, we considered all designs consisting of
I = 3,4, 5, 6, 8, or Imax laboratories3),
J = 4,5, 7,10, or 15 series,
Ê = 1 or 2 determinations per series.
For fixed Ê a design with I laboratories and J series is character-
ized by 11 J. If a design 11J covers at least as many laboratories
and series as a design Ã I J', that is if both I > Ã and J > Ã hold,
then we call the design I I J larger than the design Ã I J'. Con-
versely, the design 11J is called smaller than the design !' I J'
ifbothKI'andKJ'hold.
According to each design i.e. for each I, J, and K and for each of
the 7 constituents mentioned above an experiment was simulated
using our experimental data: I out of the Imax laboratories were
randomly selected by using a random number generator. The first
J valid series of these laboratories were processed. If K = 1 the
first values only of these series of the selected laboratories were
selected, but if K = 2 both values were taken. The same random
selection of I laboratories was used for all designs covering exactly
I laboratories, for each fixed constituent. These designs differ
with respect to J or K only. For different I however a new
randomization was performed. Moreover, for each of the 7
constituents a new randomization was performed.
We computed the following quantities according to each
design, each randomization, and each evaluation procedure:
- The assigned value. The assigned value is called the reference
assigned value4), when I = Imax, J = 15, and K = 2.
- The uncertainty interval of the assigned value, and
- its width. The width of the uncertainty interval of the refer-
ence assigned value is also used as a reference quantity.
Each design was simulated Tj times by forming TI randomiza-
tions as described above, see table 1. In doing so it was taken
care that all Imax laboratories were met equally frequently
namely ITi/Imax (being an integer) times, and that all random-
izations were pairwise different. Thus a sample of size ±1 was
3) 'max depends on the respective constituent and is identical
to the number of laboratories underlying this .study, see
table 1.
4) The reference assigned value depends on the respective
evaluation procedure.
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Tab. 1. Number of replications of individual randomization steps.
Constituent *max
Number I of laboratories selected
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a) number of laboratories underlying this study.
b) number Tj of individual randomizations of the first as well as of the second set, respectively, corresponding to approx. 1% of the
number of randomizations existing in total.
c) number Tt of individual randomizations of the total set.
d) number TI = Tt of individual randomizations of the first and of the total set corresponding to 100% of the number of randomiza-
tions existing in total.
drawn out of the population of randomizations existing in total
and having size5) ilflJaxV
This complete process was performed independently even
twice for each constituent and each chosen number of labor-
atories covering approximately 7% of the randomizations
existing in total. This resulted in a first and a second set of
randomizations. Both sets formed the total set of randomiza-
tions; yet, identical randomizations occurring accidentally
both in the first and in the second set were considered only
once6). In particular if TI already corresponded to 100%
the first set was identical to the total set of randomizations.
The total set covered Tt randomizations.
To condense all these details, we calculated two objective
quantities from the total set of randomizations for each con-
stituent, each design, and each evaluation procedure:
- The median of the individual assigned values, and
- the median of the widths of the pertaining uncertainty
intervals.
These objective quantities arc judged by means of criteria
concerning robustness and concordance. In order to visualize
this judgement both objective quantities are plotted against
I and J separately for K = 1 and K = 2. We perform two steps.
Step 1
In order to find an appropriate evaluation procedure the
totality of results underlying each plot of each figure is scored
as follows:
Score 2
The simulation results show high robustness i.e. they depend
on the respective design as little as possible indicated by a small
variation. Moreover, they are well concordant with the reference
assigned value or the width of its uncertainty interval.
To be specific, for all designs larger7) than 615, with one excep-
tion at most, the following condition is to hold: The median of
s) The definition of the binomial coefficient is
1 · 2 · 3 · . . . - b
see e.g. I.e. (8).
6) Mathematically speaking, the total set is the union of the
two sets.
7) Sec the discussion for the distinction of 615.
the individual assigned values differs from the reference assigned
value by less than one in the last relevant decimal place given by
the respective analytical method. As to the widths, the median of
the widths of the pertaining uncertainty intervals differs from the
width of the uncertainty interval of the reference assigned value
by about 8% or less.
Score 1
The simulation results show sufficient robustness for most
designs larger than 615 whereas their concordance may be less.
Score 0
The simulation results do not show sufficient robustness for
designs larger than 615.
The scores are summed up over all constituents. An evaluation
procedure yielding a distinctly larger sum of scores both for
K = 1 and K = 2 is better than one with a smaller sum0).
To summarize, each plot is judged as a whole. An appro-
priate score is attached to the sector of the plot defined by
the design 615.
Step 2
Conversely, in order to find an optimized design we look for a
sector defined by D* and having score 2 with the modification
that 615 is replaced by D*. Such a design D* is said to have suf-
ficient sample size. If in the case of K = 1 the assigned value of
the design Imax 115 differs from the reference assigned value
by at least one in the last relevant decimal place, a design D* is
also said to have sufficient sample size if the following modified
condition holds: The medians of the individual assigned values
of all designs larger than D* differ from the median of the
individual assigned values of D* by less than one on the last
relevant decimal place for all but one. An analogous condition
holds to the widths.
In other words, for eacli constituent, each K, and each objective
quantity a design D* is said to have sufficient sample size if
- all larger designs give approximately the same result, with no
more than one exception, and if secondarily
- the assigned value of D* or the width of its uncertainty
interval is concordant with the reference assigned value or
with the width of its uncertainty interval as closely as
possible.
8) Since the scores arc given to the whole plot the selection of a
procedure is uniformly valid for all designs larger than 615.
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There are always several designs D* of sufficient sample size.
For each constituent and each K, those D* for which a smaller
design of sufficient sample size does not exist are called minimal.
It must be noted that there may exist several minimal D*. There-
fore, we try to find an optimized design by selection of a minimal
design out of the set of all designs with sufficient sample size.
Naturally, such a minimal design causes as little as possible ex-
perimental expenditure.
The following connection holds between step 1 and step 2: If
the score 2 is attached in step 1 then there is a D* equal to or
smaller than 615. The converse need not be true.
Results
Figures 1 to 7 show the first results of the simulation;
these are the medians of individual assigned values
depending on the respective design.
The scale of the respective figures is given in table 2.
Generally, the results obtained by procedure 1 show
less robustness and less concordance than those given
by the procedures 2 and 3. Therefore, the assigned
values according to procedure 1 are less stable with



























































a) The distance between the lower boundary of the red net and
the black basic line correspounds to 1.0% of the reference
assigned value. Note that the black crossing points represent
medians of Tt values, see table 1.
respect to precision and accuracy so that procedure 1
turns out to be less appropriate. Procedure 2 and pro-








Fig. 1. Creatinine: Medians of individual assigned values.
The left column of plots is based on the first values only (K = 1), the right one on both values (K = 2) of the double determina-
tions, and the lines correspond to the three evaluation procedures. The medians computed from the total set of individual
randomization steps are plotted three-dimensionally in black against the respective design i.e. the number of laboratories and
of series. Extreme medians are truncated at ± scale, see table 2. The red net gives the reference assigned value as a-reference
coordinate. Therefore, for K = 2 the black and the red point coincide in the upper edge.
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Fig. 3. Urea: Medians of individual assigned values. For details see figure 1.











MODEL 2 MODEL 2
MODEL 3 MODEL 3
Fig. 4. Alanine aminotransferase: Medians of individual assigned values. For details see figure 1.
MODEL 1 MODEL I
MODEL 2 MODEL 2
MODEL 3 MODEL 3
Fig. 5. Aspartate aminotransferase: Medians of individual assigned values. For details see figure 1.
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Fig. 7. ã-Glutamyltransferase: Medians of individual assigned values. For details see figure 1.
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The judgement of procedure 2 is now described in detail
in the case of creatinine. Table 3 contains the medians
of individual assigned values when using the first values
only. As the reference assigned value is 310 ìôçïÀ/l three
designs (615 and 815 and 915) differ by 1 ìçéïÀ/À from
the reference assigned value whereas the other designs
larger than 615 have a corresponding median. Therefore,
the score 2 cannot be attached whereas the score 1 is
appropriate.
The results of judgement of all plots according to pro-
cedure 2 and procedure 3 are given in table 4. It should
be stressed that the plots of each figure are based on the
same randomizations. Therefore, for fixed I, differences
between plots are not caused at random, but they are
completely due to the different evaluation procedures,
and to K.
The score 2 is not assigned in certain cases. In doing so
the constituents are weighed. Procedures 2 and 3 cannot
be discriminated here, neither for Ê = 1 nor for Ê = 2.
Moreover, the respective reference assigned values are
well concordant with each other, see table 2.
Figures 8 to 14 show the other results of the simulation
that are the medians of widths of the pertaining uncer-
tainty intervals, depending on the respective design.
The scale of these figures is given in table 5.
The results of the judgement of procedures 2 and 3
both for Ê = 1 and Ê = 2 are given in table 6.
Tab. 3. Medians of individual assigned values for creatinine








































The results of all designs covering at least 6 laboratories and
5 series are framed.





















































a) The meaning of the scores is given in Materials and Methods.






Fig.· 8. Creatinine: Medians of widths of uncertainty intervals of assigned values.
For details see figure 1, the scale is given in table 5. However, the red net gives the width of the uncertainty interval of the
reference assigned value according to the respective procedure so that for K = 2 the black and the red point coincide in the
upper edge. Its height is identical for plots within lines but not necessarily within columns, the width according to procedure
3 may be higher than according to procedure 2 but not smaller.
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Fig. 11. Alanine aminotransferase: Medians of widths of uncertainty intervals of assigned values. For details see figure 8.
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Fig. 12. Aspartate aminotransferase: Medians of widths of uncertainty intervals of assigned values. For details see figure 8.
MODELS 1 .2
M O D E L 3
MODELS I , 2
MODEL 3
Fig. 13. Creatine kinase: Medians of widths of uncertainty intervals of assigned values. For details see figure 8.
Tab. 5. Scale of figures 8 to 14.
Width*)
Constituent Ab) Scaled Unit
Pro- Pro-
Tab. 6. Scores of plots of figures 8 to 14*).
cedure cedure
2 3
Creatinine 40 20.5 59 62 pmol/l
Glucose 1.1 0.3 1.4 1.4 mmol/1
Urea 1.3 0.45 1.7 1.8 mmol/1
Alanine amino- 7.0 2.0 8.8 9.2 ' U/l
transferase
Aspartate amino- 4.0 0.95 4.8 5.1 U/l
transferase
Creatine kinase 64 23.5 77 98 U/l
7-Glutamyl- 3.8 1.55 4.9 5.8 U/l
transferase
a) width of uncertainty interval of reference assigned value,
b) the plotted quantity is (width-A)/scale giving the same scale
to both procedures. Note that the black crossing points


















































a) see table 4 for explanations.
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Fig. 14. -y-Glutamyltransferase: Medians of widths of uncertainty intervals of assigned values. For details see figure 8.
Therefore, procedure 2 is superior to procedure 3 for
both K. Consequently, procedure 2 is selected from our
three procedures, and hereafter we restrict ourselves
to it when looking for an optimized design.
Table 7 is derived from figures 1 to 14 and gives minimal
designs of sufficient sample size in the respective case
according to procedure 2.
In particular, in the case of creatinine all designs larger
than D* = 617 give a median of individual assigned
values of 310 jLtrrjol/l corresponding to the reference as-
signed value when using the first values only (cf. tab. 3).
Additionally, D* = 3115 has also sufficient sample size
though the design 5115 being larger than 3115 differs
by 1 ìôçïÀ/À from the reference assigned value. But by
our criterion one such exception is admitted.
. It should be stressed that for fixed I and for each con-
stituent the same randomizations are used. Therefore,
variations between results of different designs may be






















































a) deviation from reference assigned value.
b) width of uncertainty interval.
c) see table 4 for explanations.
d) 6 laboratories with 7 independent series each.
e) design is smaller than 615 (see text for definition) in accordance with score 2 in tables 3 or 5.
f) design is smaller than 615. The score 1 in tables 4 or 6 is caused by worse correspondence with the red net.
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influenced at random only in cases of differing numbers
of laboratories.
No design is distinguished here either in the case of
K = 1 or of K = 2. It is a well known fact (3) however
that generally the variation between laboratories is larger
than between series which is again larger than the varia-
tion within series. Finding the number of laboratories is
therefore the most sensitive and thus the most important
step when searching for an appropriate design. That is
why this step must be performed at first.
From table 7 it can be stated that there does exist a
design of sufficient sample size requiring 6 laboratories
at most. This statement holds for both objective quanti-
ties and both cases of K for every constituent.
Discussion
The Tt randomization steps are performed using the
given Imax = 9 or 11 laboratories repeatedly so that the
results of all randomization steps are not independent.
Table 8 shows the expected number of joint labor-
atories if I laboratories are selected from Imax labor-
atories. This number increases rapidly if I is enlarged.
This fact causes an increasing dependence of the indi-
vidual results. The range of the distribution decreases
systematically if I is enlarged whereas its median is
expected to be estimated correctly for all I. That is
why we studied the medians only, whereas the ranges
of respective distributions were neglected.
When establishing an assigned value in practice how-
ever a single value is produced for each constituent, and
not a median of a set of values. But a single value has
a larger variation than a median. Both variations differ
by %/Tt at most9) (see tab. 1). This factor depends on
the number I of laboratories selected, whereas it is
constant for all numbers J of series, both K i.e. single
Tab. 8. Expected number of joint laboratories if I from Imax























9) All results obtained are simulated from a pool of Imax
laboratories. Therefore the results are not independent and
the variation of a median need not follow the vTt - law.
Rather, it is likely that for Tt larger than a certain relative low
threshold the variation of a median does not depend on Tt
any more.
as well äs double determinations, and for all evaluation
procedures for fixed I.
When comparing scores in order to distinguish a. pro-
cedure the factor VTt is irrelevant because it is in-
dependent of the respective plot. Therefore, the
distinction of procedure 2 remains valid even for an
actual establishment of assigned values, though it has
been derived originally from medians.
However, the factor \/Tt should be taken into con-
sideration when individual plots are studied in order to
distinguish a design. For I < Imax they differ at most by
factor V2 « 1.4 for creatinine, glucose, urea, creatme
kinase and -ghitamyltransferase, and by .\/3 « 1.7 at
most for alanine and aspartate aminotransferase. When
planning the simulation we had to select from two con-
tradicting strategies:
Either to perform an equal number of randomizations
for each I, or to have constant proportions both as far
as actually permitted by combinatorics. The first
strategy would result in different proportions relative
to | maxj ̂ d thus produce another kind of variation
between designs of different I concerning representativ-
ity of samples of randomizations. The latter one how-
ever would result in unequal numbers Tt and the men-
tioned consequences. We preferred our strategy of con-
stant proportions because its influence on the results
can be assessed more easily: Designs D which are larger
than the designs D* of sufficient sample size given in
table 6 approximately yield the same result as D*,
though they are often based on a smaller number of
randomizations than D* itself. This holds especially for
the designs D with I = Imax which are based on one
randomization only. Therefore, if these designs D would
be based on the same number as D* it could be expected
that their results would also be approximately concor-
dant with those of D*.
In using medians we have seen from our study that up
to 6 laboratories are required. It can be concluded that
6 laboratories will in general be sufficient for an actual
establishment of assigned values.
The further characteristics of an optimized design can-
not be derived from figures 1 to 14. Rather, we need
some additional information. Since we restrict our-
selves now to the fixed number of 6 laboratories the
dependence between the individual randomization
steps caused by repeated randomization out of the
given Imax laboratories is identical. Therefore, the
complete distributions of all individual randomization
steps may be compared. This will lead to the optimized
design (7): It covers 6 laboratories each performing
5 series.
The design 6| 5 is the limiting one in the criteria for
judging when we distinguish a procedure. I£iye had
started from a design D0 other than 6| 5 for judging
J. Gun. Chem. Clin, Biochem. / Vol. 19,1981 / No. 12
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we would not have attained a clear decision between
procedure 2 and 3 except D0 would have been larger
than 61 5. In this case we would have also chosen pro-
cedure 2.
Certain laboratories are selected out of a set of labor-
atories for an actual establishment of assigned values.
We simulated this by random selection of laboratories
from our pool of Imax laboratories. Furthermore, each
laboratory performs analyses in a natural order and the
result of each analysis may be influenced by the previous
ones. That is why we did not randomize the series but
used them according to their given order. Finally, we
used the given analytical data only and we did not per-
form any interpolation in order to simulate a con-
tinuous distribution. Thus it was unnecessary to assume
a distribution of the data for the sake of the perform-
ance of the simulation. The disadvantage however is
that single extreme values which have not been elimin-
ated by means of the controls may bias the results more
easily.
Originally, we had performed one set of randomizations
only for each constituent. In order to check whether
the proportion out of all randomizations existing in
total was sufficiently large we performed the second
set. The results of both sets corresponded very well
with each other so that the randomization error due
to sampling was sufficiently small and the first set was
large enough9). We have based our results on both sets
for the sake of completeness only.
It is an elementary statistical fact that the precision
of estimations increases if the number of underlying
values is enlarged — provided that all values are indepen-
dent and identically distributed. Therefore it is obvious
to take the assigned value which is based on all namely
2 · 15 · Imax > 270 values as a reference quantity.
Actually, these assumptions need not be fulfilled and
certain values may randomly bias the reference assigned
value or the results obtained from smaller designs.
Especially, the results for K = 1 need not be concordant
with those for K = 2, see figure 5. That is - when judging
the figures — why we stress more the robustness than
the concordance with the red net, and why the results
of one design may be neglected. On the other hand, the
criterion of concordance is essential too, because it
reflects the accuracy of results obtained from smaller
designs relative to the largest design enclosed in the
study.
For all three procedures the width of the respective
uncertainty interval is expected to increase if a relatively
small number n of values involved is enlarged. This
theoretical aspect is immediate from the definition of
how to truncate 5% of the values. But for large n the
widths of the uncertainty intervals are expected to con-
verge to a limiting width. The width of the uncertainty
interval of the optimal assigned value, which is based on
at least 270 values, is considered as limiting width and
therefore also used as a reference quantity. The fact that
the median of widths of many designs, especially of the
small ones, is below the red net is now explained as a
systematical effect which must be expected. Moreover,
small uncertainty intervals are not representative for the
analyses in the customer's laboratory. Therefore, the
comparison with the red net is essential in order to
ensure that the width is large enough. In fact this is more
important than the comparison of the assigned values
themselves with the red net because of the systematical
aspect. Yet, the width of the uncertainty interval of the
reference assigned value or of a smaller design is in-
fluenced randomly to a much higher degree than the
assigned values themselves, see figures 10,11,14. We
cover these two opposite facts by giving less weight to
the criterion of concordance than to robustness, just as
above.
There are also theoretical arguments supporting the
distinction of procedure 2, which was selected on the
basis of our experimental data.
First. The assigned value of procedure 1 is defined as
the mean of two extreme values which are naturally not
robust. Therefore the assigned value is extremely sensi-
tive as shown by the simulation. Furthermore, procedure
1 gives a symmetrical uncertainty interval which is justi-
fied only if the distribution of the underlying analytical
data is symmetrical. This assumption generally fails
(3,4). Moreover, an erroneously assumed symmetry of
the uncertainty interval may mislead the customer as
discussed in I.e. (3).
Secondly. The assigned values of procedures 2 and 3 must
approximately be concordant with each other because
they are both medians of remaining values derived from
the same set of analytical data being differently truncated
only. This is why neither procedure can be distinguished
using assigned values only. On the other hand, the
different techniques concerning the elimination of ex-
treme values either do (procedure 2) or do not (pro-
cedure 3) reflect the fact that the underlying distribu-
tions are skew. Therefore, procedure 2 must be superior.
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